Valuation: Johnson & Johnson

Capitalization 555B 475B 434B 414B 761B 53,111B 768B 5,185B 2,016B 25,197B 2,081B 2,037B 87,830B P/E ratio 2026 *
24.7x
P/E ratio 2027 * 22.4x
Enterprise value 573B 491B 448B 427B 785B 54,823B 793B 5,352B 2,081B 26,009B 2,148B 2,103B 90,661B EV / Sales 2026 *
5.68x
EV / Sales 2027 * 5.24x
Free-Float
77.1%
Yield 2026 *
2.31%
Yield 2027 * 2.41%
1 day-0.01%
1 week+2.75%
Current month+0.41%
1 month-3.01%
3 months-5.20%
6 months+18.21%
Current year+11.52%
1 week 220.37
Extreme 220.37
231.76
1 month 220.37
Extreme 220.37
240.42
Current year 200.91
Extreme 200.9101
251.71
1 year 147.33
Extreme 147.33
251.71
3 years 140.68
Extreme 140.68
251.71
5 years 140.68
Extreme 140.68
251.71
10 years 109.16
Extreme 109.16
251.71
Manager TitleAgeSince
Chief Executive Officer 63 03/01/2022
Director of Finance/CFO 59 01/07/2018
Chief Tech/Sci/R&D Officer 60 05/11/2019
Director TitleAgeSince
Director/Board Member 62 15/10/2013
Director/Board Member 71 09/06/2015
Chairman 63 02/01/2023
Change 5d. change 1-year change 3-years change Capi.($)
+0.16%+2.75%+55.48%+43.55% 555B
-0.89%+1.99%+34.94%+131.73% 906B
+1.09%+2.80%+12.11%+43.23% 368B
-0.94%-2.05%+21.74%+10.73% 326B
-0.19%+1.28%+34.97%+14.40% 289B
+0.78%+1.00%+29.63%+26.23% 285B
-0.04%-0.13%+48.00%-3.18% 280B
+0.91%+2.12%-31.78%-49.10% 208B
-0.07%+1.55%+24.32%+44.34% 182B
-0.74%-3.11%+30.20%+68.94% 165B
Average +0.07%+0.74%+25.96%+33.09% 356.36B
Weighted average by Cap. +0.06%+1.08%+30.52%+51.32%

Financials

2026 *2027 *
Net sales 101B 86.45B 78.99B 75.3B 138B 9,660B 140B 943B 367B 4,583B 379B 371B 15,975B 107B 91.89B 83.96B 80.03B 147B 10,268B 149B 1,002B 390B 4,871B 402B 394B 16,980B
Net income 22.05B 18.9B 17.27B 16.46B 30.25B 2,112B 30.55B 206B 80.14B 1,002B 82.75B 80.99B 3,492B 24.34B 20.86B 19.06B 18.17B 33.39B 2,331B 33.72B 228B 88.47B 1,106B 91.35B 89.41B 3,855B
Net Debt 17.88B 15.32B 14B 13.34B 24.52B 1,712B 24.76B 167B 64.97B 812B 67.08B 65.65B 2,831B 7.03B 6.03B 5.51B 5.25B 9.65B 674B 9.74B 65.76B 25.57B 320B 26.4B 25.84B 1,114B
Logo Johnson & Johnson
Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows: - pharmaceutical products (64.1%): drugs intended for the treatment of cardiovascular diseases, oncological diseases, gastro-intestinal illnesses, infectious, immunological, neurological, dermatological diseases, etc.; - medical products and equipment (35.9%): diagnostic systems, orthopedic and gynecological equipment, surgical materials, etc. for use by healthcare professionals; At the end of 2025, Johnson & Johnson has 63 manufacturing facilities located in the United States (22), North America (7), Europe (22), Africa and Asia/Pacific (12). The United States accounts for 57.1% of net sales.
Employees
138,200
Date Price Change Volume
14/05/26 230.80 $ +0.16% 5,730,878
13/05/26 230.42 $ +2.75% 7,464,490
12/05/26 224.26 $ +1.28% 8,632,470
11/05/26 221.43 $ +0.05% 6,223,182
08/05/26 221.32 $ -0.53% 5,550,555
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
230.42USD
Average target price
252.96USD
Spread / Average Target
+9.78%

Quarterly revenue - Rate of surprise